The document discusses the role of SAS in clinical trials, outlining the phases of trials from initial safety testing to post-marketing surveillance. It highlights the importance of SAS for data capture, statistical analysis, and reporting necessary for regulatory submissions. Additionally, it identifies licensing authorities involved in the oversight of clinical trials in various regions.